The relationships that matter most tend to find founders who build something worth noticing.
Drs Cheson and Park briefly review previous data from the E7438-G000-101 trial on tazemetostat in patients with wild-type or EZH2-mutant R/R FL, and then describe the findings of a more recent 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results